Related Experiment Video
Updated: Jun 12, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Challenges and complications in juvenile localized scleroderma: A practical approach
Clare E Pain1, Kathryn S Torok2
1Department of Rheumatology, Alder Hey Children's NHS Foundation Trust, Eaton Road, Liverpool, UK; Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
Insights
Juvenile localized scleroderma involves inflammation and fibrosis. This review offers management strategies for challenging craniofacial and extracutaneous involvement in children, addressing limited evidence.
Area of Science:
- Pediatric Rheumatology
- Dermatology
- Immunology
Background:
- Juvenile localized scleroderma (JLS) involves inflammation leading to skin and soft tissue fibrosis.
- Severe JLS subtypes, including linear and craniofacial, are prevalent in children.
- Extracutaneous involvement affects 50% of pediatric patients, correlating with worse outcomes and quality of life.
Purpose of the Study:
- To provide a practical management approach for craniofacial and extracutaneous JLS in children.
- To address the lack of evidence and clinical challenges in managing these JLS features.
- To present available evidence, current recommendations, and management considerations through case studies.
Main Methods:
- Literature review focusing on evidence for managing craniofacial and extracutaneous JLS.
- Case study presentations illustrating management strategies.
- Synthesis of current recommendations and clinical considerations.
Main Results:
- Identification of challenges in managing severe JLS subtypes.
- Highlighting the association of extracutaneous involvement with poorer prognosis.
- Demonstrating practical management approaches through case examples.
Conclusions:
- Management of craniofacial and extracutaneous JLS remains challenging due to limited evidence.
- A practical, evidence-informed approach is crucial for improving outcomes in affected children.
- Further research is needed to establish definitive treatment guidelines for these JLS manifestations.
Abstract:
Juvenile localized scleroderma is characterised by inflammation which drives fibrosis in skin and soft tissues. The more severe subtypes of localized scleroderma such as linear and craniofacial are more common in children. Additionally, extracutaneous involvement is seen in half of all children and is associated with poorer treatment outcomes and health-related quality of life. Evidence for the management of craniofacial and extracutaneous involvement is lacking and therefore poses a challenge to clinicians. This review aims to provide a practical approach to management of these most challenging features of juvenile localized scleroderma through case studies where we present the available evidence, current recommendations and considerations for management.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

